Search

everythinglearnresearchcommunity

for

Search:↓

JAK inhibitors may soon be a safe and effective treatment for alopecia areata.

Recent advances in hair loss treatments show significant progress.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

The document concludes that oral finasteride and topical minoxidil are effective for genetic hair loss, while other treatments for different types of hair loss show promise but need more research.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

A patient with complete hair loss regrew all her hair using tofacitinib.

The document concludes that side effects from Smoothened inhibitor drugs for skin cancer are reversible and can be managed with a team approach to maintain quality of life.

The study found that expanded skin regenerates similarly to normal skin, with 77 genes playing a role in the process.

CD1d expression in scalp skin and hair follicles changes with the hair cycle and may help protect against microbes.

Low-dose tofacitinib is effective and cheaper for severe alopecia areata.

An 11-month-old boy with Menkes disease had severe brain shrinkage and abnormal blood vessels, and didn't respond well to treatment.

Upadacitinib effectively treated severe hair loss in a child.

Telocytes in the scalp may help with skin regeneration and maintenance.

New JAK inhibitor drugs show promise for treating skin diseases but need more research on safety and effectiveness.

Tofacitinib, an arthritis drug, helped hair growth in alopecia universalis but long-term safety needs more research.

The document concludes that a new system using the SALT score should replace the current alopecia areata classification for better accuracy in assessing severity and prognosis.

The document concludes that diagnosing and treating hair loss is complex and requires understanding its psychological effects and underlying causes, while also calling for more research and new treatments.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

New, effective treatments for alopecia areata require innovative approaches targeting the immune system.

Upadacitinib improved Crohn's disease, atopic dermatitis, and alopecia areata in one patient.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Alopecia areata is a chronic condition causing hair loss, with new treatments targeting the immune system showing promise.

A Brazilian teenager with severe hair loss had total hair regrowth with no side effects after using tofacitinib.

Stopping JAK inhibitor treatment for hair loss can lead to worse hair loss than before the treatment.

Urinary Se to creatinine ratio, serum Se, and glutathione peroxidase are effective early biomarkers for selenium status in dogs.

Chronic ethanol increases certain brain receptor levels, influenced by steroids and protein changes.

Enzymatic phosphorylation of hair keratin improves the effectiveness of hair products with cationic ingredients.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.